The Christie NHS FT Annual Report & Accounts 2019-20

Our financial performance

Performance for the financial year ended 31 st March 2020

Group

Trust

Year on year change

Year on year change

2019-20 actual

2018-19 actual

2019-20 actual

2018-19 actual

£m

£m

£m

£m

£m

£m

Total income

359.7

336.8

22.9

352.3

335.8

16.5

Total operating expenditure (excluding depreciation and net impairments) EBITDA*

(317.6)

(271.8)

(45.8)

(317.9)

(272.2)

(45.7)

42.1 (0.1)

65.0 (1.8)

(22.9)

34.4

63.6

(29.2)

Gain / (loss) on revaluation and disposal of investment assets

1.7

0.0

0.0

0.0

Gain / (loss) on disposal of assets Depreciation and amortisation

(0.0)

(0.2)

0.2

0.0

0.0

0.0

(17.1)

(14.2)

(2.9)

(17.1)

(14.2)

(2.9)

Dividend

(7.4) (0.3) (0.1)

(7.4) (0.6) (0.1)

0.0 0.3 0.0 0.2

(7.4) (0.7)

(7.4) (1.0)

0.0 0.3 0.0 0.2

Net finance charge Corporate tax expense

0.0 6.0

0.0 5.8

Share of Joint Venture (equity method)

6.0

5.8

Retained surplus

23.1

46.5

(23.4)

15.2

46.8

(31.6)

(before exceptional items) Exceptional items** Retained surplus / (deficit)

3.9

(18.0)

21.9 (1.5)

3.9

(18.0)

21.9 (9.7)

27.0

28.5

19.1

28.8

* EBITDA is earnings before interest, tax, depreciation and amortisation **Exceptional items represent building asset impairment and reversal of impairments

Total clinical income has increased by £52.6m (22.1%) over the last 12 months. This represents a significant investment by our commissioners to provide additional cancer treatments and the best safety and quality of care available for the population we serve. Provision of goods and services Section 43(2A) of the NHS Act 2006 requires that the income from the provision of goods and services for the purposes of the health service in

The results represent increasing levels of activity, improved efficiency and cost control across all areas of the organisation. Activity and income The Trust receives the majority of its income for delivering patient care, which equated to £291.0m in 2019-20. Of this total, the Trust received £245.1m during the year from its principal commissioner, NHS England, and £33.5m from clinical commissioning groups.

31